Routine: IBDEI361

IBDEI361 ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,50549,2)

 ;;=^5019599

 ;;^UTILITY(U,$J,358.3,50550,0)

 ;;=Z87.442^^193^2494^84

 ;;^UTILITY(U,$J,358.3,50550,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50550,1,3,0)

 ;;=3^Personal Hx of Urinary Calculi

 ;;^UTILITY(U,$J,358.3,50550,1,4,0)

 ;;=4^Z87.442

 ;;^UTILITY(U,$J,358.3,50550,2)

 ;;=^5063497

 ;;^UTILITY(U,$J,358.3,50551,0)

 ;;=N18.1^^193^2494^15

 ;;^UTILITY(U,$J,358.3,50551,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50551,1,3,0)

 ;;=3^Chronic Kidney Disease,Stage 1

 ;;^UTILITY(U,$J,358.3,50551,1,4,0)

 ;;=4^N18.1

 ;;^UTILITY(U,$J,358.3,50551,2)

 ;;=^5015602

 ;;^UTILITY(U,$J,358.3,50552,0)

 ;;=N18.2^^193^2494^16

 ;;^UTILITY(U,$J,358.3,50552,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50552,1,3,0)

 ;;=3^Chronic Kidney Disease,Stage 2

 ;;^UTILITY(U,$J,358.3,50552,1,4,0)

 ;;=4^N18.2

 ;;^UTILITY(U,$J,358.3,50552,2)

 ;;=^5015603

 ;;^UTILITY(U,$J,358.3,50553,0)

 ;;=N18.3^^193^2494^17

 ;;^UTILITY(U,$J,358.3,50553,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50553,1,3,0)

 ;;=3^Chronic Kidney Disease,Stage 3

 ;;^UTILITY(U,$J,358.3,50553,1,4,0)

 ;;=4^N18.3

 ;;^UTILITY(U,$J,358.3,50553,2)

 ;;=^5015604

 ;;^UTILITY(U,$J,358.3,50554,0)

 ;;=N18.4^^193^2494^18

 ;;^UTILITY(U,$J,358.3,50554,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50554,1,3,0)

 ;;=3^Chronic Kidney Disease,Stage 4

 ;;^UTILITY(U,$J,358.3,50554,1,4,0)

 ;;=4^N18.4

 ;;^UTILITY(U,$J,358.3,50554,2)

 ;;=^5015605

 ;;^UTILITY(U,$J,358.3,50555,0)

 ;;=N18.5^^193^2494^19

 ;;^UTILITY(U,$J,358.3,50555,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50555,1,3,0)

 ;;=3^Chronic Kidney Disease,Stage 5

 ;;^UTILITY(U,$J,358.3,50555,1,4,0)

 ;;=4^N18.5

 ;;^UTILITY(U,$J,358.3,50555,2)

 ;;=^5015606

 ;;^UTILITY(U,$J,358.3,50556,0)

 ;;=Q61.3^^193^2494^87

 ;;^UTILITY(U,$J,358.3,50556,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50556,1,3,0)

 ;;=3^Polycystic Kidney,Unspec

 ;;^UTILITY(U,$J,358.3,50556,1,4,0)

 ;;=4^Q61.3

 ;;^UTILITY(U,$J,358.3,50556,2)

 ;;=^5018797

 ;;^UTILITY(U,$J,358.3,50557,0)

 ;;=N20.1^^193^2494^11

 ;;^UTILITY(U,$J,358.3,50557,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50557,1,3,0)

 ;;=3^Calculus Ureter

 ;;^UTILITY(U,$J,358.3,50557,1,4,0)

 ;;=4^N20.1

 ;;^UTILITY(U,$J,358.3,50557,2)

 ;;=^5015608

 ;;^UTILITY(U,$J,358.3,50558,0)

 ;;=N18.9^^193^2494^20

 ;;^UTILITY(U,$J,358.3,50558,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50558,1,3,0)

 ;;=3^Chronic Kidney Failure,Unspec

 ;;^UTILITY(U,$J,358.3,50558,1,4,0)

 ;;=4^N18.9

 ;;^UTILITY(U,$J,358.3,50558,2)

 ;;=^332812

 ;;^UTILITY(U,$J,358.3,50559,0)

 ;;=N18.6^^193^2494^30

 ;;^UTILITY(U,$J,358.3,50559,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50559,1,3,0)

 ;;=3^End Stage Renal Disease (ESRD)

 ;;^UTILITY(U,$J,358.3,50559,1,4,0)

 ;;=4^N18.6

 ;;^UTILITY(U,$J,358.3,50559,2)

 ;;=^303986

 ;;^UTILITY(U,$J,358.3,50560,0)

 ;;=N52.9^^193^2494^47

 ;;^UTILITY(U,$J,358.3,50560,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50560,1,3,0)

 ;;=3^Erectile Dysfunction,Unspec

 ;;^UTILITY(U,$J,358.3,50560,1,4,0)

 ;;=4^N52.9

 ;;^UTILITY(U,$J,358.3,50560,2)

 ;;=^5015763

 ;;^UTILITY(U,$J,358.3,50561,0)

 ;;=N32.81^^193^2494^82

 ;;^UTILITY(U,$J,358.3,50561,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50561,1,3,0)

 ;;=3^Overactive Bladder

 ;;^UTILITY(U,$J,358.3,50561,1,4,0)

 ;;=4^N32.81

 ;;^UTILITY(U,$J,358.3,50561,2)

 ;;=^5015652

 ;;^UTILITY(U,$J,358.3,50562,0)

 ;;=Q61.2^^193^2494^86

 ;;^UTILITY(U,$J,358.3,50562,1,0)

 ;;=^358.31IA^4^2

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI361   3777     printed  Feb 19, 2025@00:08:56                                                                                                                                                                                                    Page 2

IBDEI361  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.3)

               QUIT

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT

 +1       ;;^UTILITY(U,$J,358.3,50549,2)

 +2       ;;=^5019599

 +3       ;;^UTILITY(U,$J,358.3,50550,0)

 +4       ;;=Z87.442^^193^2494^84

 +5       ;;^UTILITY(U,$J,358.3,50550,1,0)

 +6       ;;=^358.31IA^4^2

 +7       ;;^UTILITY(U,$J,358.3,50550,1,3,0)

 +8       ;;=3^Personal Hx of Urinary Calculi

 +9       ;;^UTILITY(U,$J,358.3,50550,1,4,0)

 +10      ;;=4^Z87.442

 +11      ;;^UTILITY(U,$J,358.3,50550,2)

 +12      ;;=^5063497

 +13      ;;^UTILITY(U,$J,358.3,50551,0)

 +14      ;;=N18.1^^193^2494^15

 +15      ;;^UTILITY(U,$J,358.3,50551,1,0)

 +16      ;;=^358.31IA^4^2

 +17      ;;^UTILITY(U,$J,358.3,50551,1,3,0)

 +18      ;;=3^Chronic Kidney Disease,Stage 1

 +19      ;;^UTILITY(U,$J,358.3,50551,1,4,0)

 +20      ;;=4^N18.1

 +21      ;;^UTILITY(U,$J,358.3,50551,2)

 +22      ;;=^5015602

 +23      ;;^UTILITY(U,$J,358.3,50552,0)

 +24      ;;=N18.2^^193^2494^16

 +25      ;;^UTILITY(U,$J,358.3,50552,1,0)

 +26      ;;=^358.31IA^4^2

 +27      ;;^UTILITY(U,$J,358.3,50552,1,3,0)

 +28      ;;=3^Chronic Kidney Disease,Stage 2

 +29      ;;^UTILITY(U,$J,358.3,50552,1,4,0)

 +30      ;;=4^N18.2

 +31      ;;^UTILITY(U,$J,358.3,50552,2)

 +32      ;;=^5015603

 +33      ;;^UTILITY(U,$J,358.3,50553,0)

 +34      ;;=N18.3^^193^2494^17

 +35      ;;^UTILITY(U,$J,358.3,50553,1,0)

 +36      ;;=^358.31IA^4^2

 +37      ;;^UTILITY(U,$J,358.3,50553,1,3,0)

 +38      ;;=3^Chronic Kidney Disease,Stage 3

 +39      ;;^UTILITY(U,$J,358.3,50553,1,4,0)

 +40      ;;=4^N18.3

 +41      ;;^UTILITY(U,$J,358.3,50553,2)

 +42      ;;=^5015604

 +43      ;;^UTILITY(U,$J,358.3,50554,0)

 +44      ;;=N18.4^^193^2494^18

 +45      ;;^UTILITY(U,$J,358.3,50554,1,0)

 +46      ;;=^358.31IA^4^2

 +47      ;;^UTILITY(U,$J,358.3,50554,1,3,0)

 +48      ;;=3^Chronic Kidney Disease,Stage 4

 +49      ;;^UTILITY(U,$J,358.3,50554,1,4,0)

 +50      ;;=4^N18.4

 +51      ;;^UTILITY(U,$J,358.3,50554,2)

 +52      ;;=^5015605

 +53      ;;^UTILITY(U,$J,358.3,50555,0)

 +54      ;;=N18.5^^193^2494^19

 +55      ;;^UTILITY(U,$J,358.3,50555,1,0)

 +56      ;;=^358.31IA^4^2

 +57      ;;^UTILITY(U,$J,358.3,50555,1,3,0)

 +58      ;;=3^Chronic Kidney Disease,Stage 5

 +59      ;;^UTILITY(U,$J,358.3,50555,1,4,0)

 +60      ;;=4^N18.5

 +61      ;;^UTILITY(U,$J,358.3,50555,2)

 +62      ;;=^5015606

 +63      ;;^UTILITY(U,$J,358.3,50556,0)

 +64      ;;=Q61.3^^193^2494^87

 +65      ;;^UTILITY(U,$J,358.3,50556,1,0)

 +66      ;;=^358.31IA^4^2

 +67      ;;^UTILITY(U,$J,358.3,50556,1,3,0)

 +68      ;;=3^Polycystic Kidney,Unspec

 +69      ;;^UTILITY(U,$J,358.3,50556,1,4,0)

 +70      ;;=4^Q61.3

 +71      ;;^UTILITY(U,$J,358.3,50556,2)

 +72      ;;=^5018797

 +73      ;;^UTILITY(U,$J,358.3,50557,0)

 +74      ;;=N20.1^^193^2494^11

 +75      ;;^UTILITY(U,$J,358.3,50557,1,0)

 +76      ;;=^358.31IA^4^2

 +77      ;;^UTILITY(U,$J,358.3,50557,1,3,0)

 +78      ;;=3^Calculus Ureter

 +79      ;;^UTILITY(U,$J,358.3,50557,1,4,0)

 +80      ;;=4^N20.1

 +81      ;;^UTILITY(U,$J,358.3,50557,2)

 +82      ;;=^5015608

 +83      ;;^UTILITY(U,$J,358.3,50558,0)

 +84      ;;=N18.9^^193^2494^20

 +85      ;;^UTILITY(U,$J,358.3,50558,1,0)

 +86      ;;=^358.31IA^4^2

 +87      ;;^UTILITY(U,$J,358.3,50558,1,3,0)

 +88      ;;=3^Chronic Kidney Failure,Unspec

 +89      ;;^UTILITY(U,$J,358.3,50558,1,4,0)

 +90      ;;=4^N18.9

 +91      ;;^UTILITY(U,$J,358.3,50558,2)

 +92      ;;=^332812

 +93      ;;^UTILITY(U,$J,358.3,50559,0)

 +94      ;;=N18.6^^193^2494^30

 +95      ;;^UTILITY(U,$J,358.3,50559,1,0)

 +96      ;;=^358.31IA^4^2

 +97      ;;^UTILITY(U,$J,358.3,50559,1,3,0)

 +98      ;;=3^End Stage Renal Disease (ESRD)

 +99      ;;^UTILITY(U,$J,358.3,50559,1,4,0)

 +100     ;;=4^N18.6

 +101     ;;^UTILITY(U,$J,358.3,50559,2)

 +102     ;;=^303986

 +103     ;;^UTILITY(U,$J,358.3,50560,0)

 +104     ;;=N52.9^^193^2494^47

 +105     ;;^UTILITY(U,$J,358.3,50560,1,0)

 +106     ;;=^358.31IA^4^2

 +107     ;;^UTILITY(U,$J,358.3,50560,1,3,0)

 +108     ;;=3^Erectile Dysfunction,Unspec

 +109     ;;^UTILITY(U,$J,358.3,50560,1,4,0)

 +110     ;;=4^N52.9

 +111     ;;^UTILITY(U,$J,358.3,50560,2)

 +112     ;;=^5015763

 +113     ;;^UTILITY(U,$J,358.3,50561,0)

 +114     ;;=N32.81^^193^2494^82

 +115     ;;^UTILITY(U,$J,358.3,50561,1,0)

 +116     ;;=^358.31IA^4^2

 +117     ;;^UTILITY(U,$J,358.3,50561,1,3,0)

 +118     ;;=3^Overactive Bladder

 +119     ;;^UTILITY(U,$J,358.3,50561,1,4,0)

 +120     ;;=4^N32.81

 +121     ;;^UTILITY(U,$J,358.3,50561,2)

 +122     ;;=^5015652

 +123     ;;^UTILITY(U,$J,358.3,50562,0)

 +124     ;;=Q61.2^^193^2494^86

 +125     ;;^UTILITY(U,$J,358.3,50562,1,0)

 +126     ;;=^358.31IA^4^2

IBDEI361.m